[HTML][HTML] Metabolomics of volatile organic compounds in cystic fibrosis patients and controls

…, Q Jöbsis, LJI Zimmermann, HJE Hendriks… - Pediatric …, 2010 - nature.com
In cystic fibrosis (CF), airway inflammation causes an increased production of reactive
oxygen species, responsible for degradation of cell membranes. During this process, volatile …

Childhood asthma: exhaled markers of airway inflammation, asthma control score, and lung function tests

…, MA Dentener, HJ Pennings, HJE Hendriks… - Pediatric …, 2004 - Wiley Online Library
Exhaled markers of airway inflammation become increasingly important in the management
of childhood asthma. The aims of the present study are: 1) to compare exhaled markers of …

Exhaled breath condensate in children: pearls and pitfalls

…, E Dompeling, HJE Hendriks… - Pediatric allergy and …, 2004 - Wiley Online Library
Exhaled breath condensate (EBC) is a rapidly growing field of research in respiratory
medicine. Airway inflammation is a central feature of chronic lung diseases, like asthma, cystic …

Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate

…, J Teunissen, J Heynens, HJ Hendriks… - European …, 2006 - Eur Respiratory Soc
Exhaled breath condensate collection is not yet standardised and biomarker measurements
are often close to lower detection limits. In the current study, it was hypothesised that …

The effect of 3% and 6% hypertonic saline in viral bronchiolitis: a randomised controlled trial

…, S Potgieter, MR Faber, HJE Hendriks… - European …, 2014 - Eur Respiratory Soc
Bronchiolitis is a common disorder in young children that often results in hospitalisation.
Except for a possible effect of nebulised hypertonic saline (sodium chloride), no evidence-based …

Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis

…, PHM Heijmans, PPR Rosias, HJE Hendriks… - Annals of Allergy …, 2006 - Elsevier
BACKGROUND: Inflammatory mediators in exhaled breath condensate (EBC) indicate ongoing
inflammation in the lungs and might differentiate between asthma and cystic fibrosis (CF) …

Actual asthma control in a paediatric outpatient clinic population: do patients perceive their actual level of control?

…, R Droog, Q Jöbsis, HJE Hendriks… - Pediatric allergy and …, 2008 - Wiley Online Library
Several epidemiological studies described poor asthma control in children. However, the
diagnosis of childhood asthma in these studies is uncertain, and asthma control in children of …

[HTML][HTML] Severe pediatric COVID-19 and multisystem inflammatory syndrome in children from wild-type to population immunity: a prospective multicenter cohort study …

…, HB van Gameren-Oosterom, H Hendriks… - The Pediatric …, 2023 - journals.lww.com
Background: SARS-CoV-2 variant evolution and increasing immunity altered the impact of
pediatric SARS-CoV-2 infection. Public health decision-making relies on accurate and timely …

Risk factors for lung disease progression in children with cystic fibrosis

…, G Wesseling, V Gulmans, H Hendriks… - European …, 2018 - Eur Respiratory Soc
To identify potential risk factors for lung disease progression in children with cystic fibrosis (CF),
we studied the longitudinal data of all children with CF (aged ≥5 years) registered in the …

Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in …

…, D van Vliet, AD Kester, HJE Hendriks… - Annals of Allergy …, 2008 - Elsevier
BACKGROUND: Extra-fine hydrofluoroalkane-beclomethasone differs from other inhaled
corticosteroids by its fine aerosol characteristics. Therefore, extra-fine hydrofluoroalkane-…